Pfizer-BioNTech COVID-19 Vaccine Tied To Lower Risk Of Developing Myocarditis, Pericarditis Or Myopericarditis Than Moderna Vaccine, Analysis Says

November 09, 2022

Cardiovascular Business (11/8) reports, “The Pfizer-BioNTech COVID-19 vaccine is associated with a lower risk of developing myocarditis, pericarditis or myopericarditis than the Moderna Spikevax vaccine, according” to an analysis of “adults who received t...